You are here

T2D

( N = 71,663 ) as of 20 Sep 2022

This is Type 2 Diabetes (T2D) cohort who were hospitalized in Ramarhibodi hospital since 2010. This cohort is available in longitudinal format where every hositorical visits were record. Also, this cohort capture the newly diagnosis of T2D after 2010. The example features are available in this are glycemic profile, lipid profile, vital sign, comorbidities (eg. hypertension, dyslipidemia, chronic kidney disease), glycemic drugs (first and secondline drugs), lipid-lowering drugs and etc.

 

Diagram

 

Variables in T2D

Click to see more variables

 

| Ongoing research topics

  • Multi-state model
  • Treatment effectiveness of second-line drugs in prevention of heart failure
  • Prognostic factors of heart failure in T2D patients
  • Effect of second-line drugs on CVD, CKD, All-cause mortality
  • Effect of second-line drugs on diabetic ratinopathy 
  • Effect of second-line drugs on fatty liver (NAFLD/NASH)
  • Effect of GLP1 on BMI
  • Cost-Utility Analysis of Laparoscopic Bariatric Surgery for Obesity with type II Diabetes Mellitus
  • Effects of second-line drugs in lowering PAD occurrence 
  • Hypoglycemic events  and economic evaluation in treatment managements of T2D patients
  • Short and Long term outcomes between patients who are treated in DM clinic vs non-DM clinic
 
Department of Clinical Epidemiology and Biostatistics